Orion Oyj
(OTC: ORINY)
|
3:14 PM UTC, 06/04/24 | |||
---|---|---|---|---|
Last: $21.30 | Change: +1.33 | %Change: +6.69% | Volume: 320 |
Open: | $ 21.30 | Volume: | 320 | |
---|---|---|---|---|
High: | $ 21.30 | Yield(%) | 1.11 | |
Low: | $ 21.30 | P/E Ratio (ttm): | 26.96 | |
Dividend ($): | 0.25 | Market Cap ($): | 4.84B | |
EPS ($) | 0.84 | Shares Out: | 214.54M |
% Price Change (last 4 weeks): | 5.82 |
---|---|
% Price Change (last 13 weeks): | 23.33 |
% Price Change (last 26 weeks): | 3.18 |
% Price Change (last 52 weeks): | 8.13 |
% Price Change (year to date): | 3.09 |
Return on Equity (%): | 24.01 |
---|---|
Return on Assets (%): | 14.64 |
Return on Invested Capital (%): | 25.76 |
Gross Profit Margin (%): | 53.77 |
---|---|
Net Profit Margin (%): | 18.20 |
Operating Profit Margin (%): | 19.64 |
|
|
50-day Moving Average: | $1.94 |
---|---|
200-day Moving Average: | $n/a |
Avg. Daily Vol. (last 50 days): | 51 |
Avg. Daily Vol. (last 200 days): | n/a |
52-wk high: | $23.62 |
52-wk low: | $17.50 |
Bid: | $n/a |
Ask: | $n/a |
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. It specializes in central nervous system disorders, oncology, and respiratory diseases. The firm's customers are specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories. The company was founded by Onni Turpeinen, Eemil Tuurala and Wikki Valkama on September 21, 1917 and is headquartered in Espoo, Finland.
|
Earnings (1year) ($): | n/a |
---|---|
Annual Dividend ($): | 0.25 |
Current P/E Ratio (ttm): | 26.96 |
Book Value ($): | 3.50 |
Cash Flow ($): | 1.35 |
Price/Earnings (x): | 26.96 |
---|---|
Price/Sales (x): | 4.77 |
Price/Book (x): | 6.24 |
Price/Cash Flow (x): | 47.73 |
Quick Ratio (x): | 1.75 |
---|---|
Current Ratio (x): | 3.12 |
LT Debt/Equity (x): | 19.21 |
Total Debt/Equity (x): | 22.48 |